Friday, June 29, 2018

On Tech Base Pcr-based and Microarray Blood Group Typing Market Is Expected to Witness the Fastest Growth During the Forecast Period (2017 – 2023)

Blood Group Typing Market

 Blood group typing is a procedure of determining what specific type of blood a person has, which depends on the presence of antigens on the red blood cells. It is done in organ donation process, to safely donate or receive a blood transfusion and to determine whether Rh factor is present on the surface of the red blood cell. Blood group typing is very important during pregnancy as it can prevent severe anaemia in the new born. There are various techniques and methods to detect the blood group. The global blood group typing market has witnessed significant growth due to the advancement in technology which has improved detection methods.

 Request to Get the Sample Report@ https://www.psmarketresearch.com/market-analysis/blood-group-typing-market/report-sample

 Globally, the demand for blood group typing products and services was largest in hospitals due to the increasing awareness regarding the importance of blood donations and growth in the requirements of blood for surgical treatments. Other key end users in the global blood group typing market are clinical laboratories and blood banks.



 North America held the largest share in the global blood group typing market in 2016, followed by Europe. It was the prominent market for the blood group typing products and services. The reasons of the dominance of North America is the presence of different reimbursement schemes for several surgeries and prevalence of chronic diseases. Asia-Pacific blood group typing market is expected to witness the fastest growth during the forecast period with the growth centered at China, Japan, and India.

 Make Enquiry Before Buying the Report@ https://www.psmarketresearch.com/send-enquiry?enquiry-url=blood-group-typing-market

 They key players in the global blood group typing market are Bio-Rad Laboratories, Inc., Immucor, Inc., Quotient Limited, BAG Health Care GmbH, DAY medical SA, Grifols S.A., Ortho Clinical Diagnostics, Inc., Novacyt Group, DIAGAST, AXO Science, and Agena Bioscience, Inc.
About P&S Market Research
P&S Market Research is a global market research and consulting company. We provide market research reports, industry reports, business intelligence and research-based consulting services across a range of industries.
With the help of our professional corporate relations with various companies, our market research offers the most accurate market forecasting. Our analysts and consultants interact with leading companies of the concerned domain to substantiate every single data presented in our publication. Our research assists our client in identifying new and different windows of opportunity and frame informed and customized strategies for expansion in different regions.

Contact:
P&S Market Research
347, 5th Ave. #1402
New York City, NY - 10016
Toll-free: +1-888-778-7886 (USA/Canada)

Posted by at No comments:
Labels: , , ,

Thursday, June 28, 2018

Single Use Bioprocessing Systems Market Comprehensive Review of its Applications, Demand, Growth Opportunities and Future Prospects

Single Use Bio Processing Systems Market
Rising demand of disposables in biopharmaceutical production, increasing prevalence of chronic diseases, which requires biological drugs for their management and treatment, low manufacturing costs of disposable products and instrument, and improving life science research infrastructure are some of the growth drivers of the global single-use bioprocessing systems market. In addition, technological advancement in bioprocessing systems is also driving the growth of global single-use bio-processing systems market. Increasing numbers of mergers and acquisitions and rapid product launches are some of the major trends, observed in the global single-use bioprocessing systems market.

 Request to Get the Sample Report@ https://www.psmarketresearch.com/market-analysis/single-use-bioprocessing-systems-market/report-sample

 Single-use bioprocessing technology is mainly used in the development and production of biopharmaceuticals. The technology is used throughout the workflow of biopharmaceutical production, starting from buffer and media preparation to bioreactor cultures for vaccines to the storage and shipping of intermediates and bulk biologics. Single-use bio-processing techniques are carried out through several products. Some of the major products include manifold assemblies, bioprocess containers and bags, single-use bioreactors, outer support containers, and single-use mixers. These products reduce cost related to the complex bioproduction procedures, such as cleaning, sterilization, and care of the large bioreactors. 



 Europe and North America are the major markets for single-use bioprocessing systems, attributed to the increased life science research and growing demand for biopharmaceuticals. Asia-Pacific market for the single-use bioprocessing systems is growing at a significant rate owing to improving life science infrastructure and increasing investment by several pharmaceutical manufacturing companies for the development of R&D plants in the region. Apart from these regions, Latin America and Middle-East are other important markets of single-use bio-processing systems.
Country wise, the U.S., followed by Canada, is the largest market for single-use bioprocessing systems in North America. Germany, the U.K., France and Italy are some of the major countries holding significant shares of single-use bio-processing systems market in Europe. In Asia-Pacific, India, Japan, and China are major markets for single-use bio-processing systems; whereas Brazil holds largest market share of single-use bioprocessing systems market in Rest of the World (RoW).
Some of the major players operating in global single-use bioprocessing systems market include Tarpon Biosystems Inc., GE Healthcare, STI Components Inc., Merck & Co Inc., Saint-Gobain Corporation, Sartorius Stedim Biotech SA, PendoTECH, ThermoFisher Scientific Inc., Parker Hannifin Corporation, Pall Corporation, Eppendorf AG, Cellexus Ltd. and Broadley-James Ltd.
Posted by at No comments:
Labels: , , ,

Cell Analysis Market Key Growth Factor Analysis & Research Study 2023

Cell Analysis Market
The global cell analysis market is growing significantly due to increasing prevalence of chronic and infectious diseases, increasing research and development activities and technological advancements in cell analysis techniques. In addition, increasing usage of cell analysis in various applications, such as target identification and validation, cell identification and viability, and single cell analysis is also supporting the growth of the global cell analysis market. Large unexplored cell analysis market in emerging economies and increasing contract research outsourcing in healthcare are creating ample opportunities for the global cell analysis market to grow at a considerable rate in the coming years.
Adoption of quantitative real-time reverse transcription polymerase chain reaction for single cell analysis is a trend in the global cell analysis market. Increasing prevalence of cancer has fuelled the demand of cell analysis instruments. Cell analysis instruments are extensively used in detection and diagnosis of cancerous cell in blood and bones. Advanced techniques of cell analysis are being used to study the cancer at the single cell level.

Some of the factors driving the growth of the global cell analysis market are increasing prevalence of infectious and chronic diseases, technological advancements in cell analysis techniques, and increasing government spending in healthcare. In addition, continuous innovations in image analysis systems and informatics are propelling the growth of the global cell analysis market. 
Geographically, North America will be leading the global cell analysis market in the coming years due to high prevalence of cancer, high research and development activities, and technological advancements in cell analysis systems. In addition, presence of large number of hospitals, pharmaceutical and biotechnology companies, and academic and research institutes is also driving the expansion of cell analysis market in North America.
Asia-Pacific is the fastest growing region in the global cell analysis market. The major reasons for the fastest growth in the region are increasing prevalence of chronic and infectious diseases, increasing healthcare expenditure, and improving healthcare infrastructure. Moreover, the cell analysis market is growing rapidly due to increasing molecular biology and genetics research, and rising adoption rate of advanced cell analysis techniques in clinical diagnostics in emerging economies, such as India and China, of Asia-Pacific.

x

Posted by at No comments:
Labels: , ,

In Forensic Technologies Market Technological Advancements Is the Major Key Growth Driver

Forensic Technologies Market
The global Forensic Technologies Market is growing significantly due to increasing rate of crime across the globe, technological advancements in forensic techniques, and increasing number of forensic laboratories. In addition, increasing demand and awareness for DNA testing are supporting growth of global forensic technologies market. Outsourcing of crime cases by government laboratories to privately held laboratories is creating ample opportunities for private players in global forensic technologies market. 

Request to Get the Sample Report@ https://www.psmarketresearch.com/market-analysis/forensic-technologies-market/report-sample

Usage of digital forensics and DNA profiling is a trend in the global forensic technologies market. DNA testing has shown great potential in solving the crime cases; hence, resulting in its increased adherence in crime investigations. With the remarkable growth of internet in the last decade, internet and computer crimes have also increased many folds. Increasing incidences of cyber-crimes is a major concern across the globe.

Full Explore Report@ https://www.psmarketresearch.com/market-analysis/forensic-technologies-market

Some of the factors driving the growth of the global forensic technologies market are increasing incidences of crime across the globe, technological advancements in forensic techniques, and peer pressure of solving crime cases. In addition, high investigator’s compliance for DNA testing, and increasing demand of mobile forensic techniques are propelling the growth of the global forensic technologies market.
Geographically, Europe and North America lead the global forensic technologies market due to high incidences of crime, technological advancements in forensic sciences, and high investigator’s compliance for advanced forensic techniques such as DNA profiling, firearm analysis, and biometric analysis techniques. In addition, presence of a large number of forensic laboratories drives forensic technologies market in Europe and North America. 
Asia-Pacific is the fastest growing region in the global forensic technologies market. The major reasons for the fastest growth in the region are increasing crime cases, increasing government funding, and technological advancements. Moreover, the forensic technologies market is growing rapidly due the ongoing DNA data base programs, and rising adoption rate of forensic techniques in emerging economies, such as South Africa and China.
Some of the major players operating in the global forensic technologies market are GE Healthcare, Agilent Technologies, Eurofins Medigenomix Gmbh, Pyramidal Technologies Ltd., Life Technologies Inc., SPEX Forensics, NMS Labs Inc., LGC Forensics among others.
Posted by at No comments:
Labels: , ,

Wednesday, June 27, 2018

Next Generation Sequencing Market Rapid Growth and Demand in Biotech Industries

Next Generation Sequencing Market

The global next-generation sequencing market is growing significantly due to advances in next-generation technologies, increasing scientists and researchers’ compliance for next-generation sequencing, and low cost of next-generation sequencing methods compared to conventional sequencing methods in the industry. The unexplored next-generation sequencing market in emerging economies and increasing focus for the development of personalized medicine are creating opportunities for the global next-generation sequencing market to grow at a considerable rate in the coming years. 


Usage of nanopore sequencing technology for the development of next-generation sequencing platforms is a trend in global next-generation sequencing market. Next-generation sequencing provides high throughput sequencing to researchers and scientists with high specificity and speed, and reduced cost. Conventional sequencing methods, such as Sanger method that are slower, expensive and require large amount of template DNA next-generation sequencing, has overcome these limitations with more accurate results.


Some of the factors driving the growth of the global next-generation sequencing market are advances in sequencing technology, increasing adherence of researchers and scientists for next-generation sequencing, increasing demand for quicker, cheaper and accurate sequencing methods, and increasing research and development activities in genomics and proteomics. In addition, the National Human Genome Research Institute’s goal to reduce human genome sequencing cost upto 100 times is propelling pharmaceutical and biotechnology companies to invest large capital for the development of next-generation sequencing; this in turn is expected to drive the global next-generation sequencing market. 
Geographically, North America will be leading the global next-generation sequencing market in the coming years due to high healthcare expenditure, technological advancements, presence of large number of academic and research institutes, and high scientists’ compliance for next-generation sequencing devices. Asia-Pacific is the fastest growing region in the global next-generation sequencing market. The major reasons for the fastest growth in the region are increasing healthcare expenditure, increasing genomics and proteomics related research activities and improving healthcare infrastructure. Moreover, the next-generation sequencing market is growing rapidly due to the government funding for research activities, and increasing number of academic and research institutes in emerging economies, such as India and China, of Asia-Pacific region.
Some of the major players operating in the global next-generation sequencing market are Agilent Technologies, Inc., F. Hoffmann-La Roche AG, Biomatters, Ltd., GATC Biotech AG, Illumina, Inc., Thermo Fisher Scientific, Inc., Pacific Biosciences, Oxford Nanopore Technologies, Ltd, Macrogen, Inc. among others.
x
Posted by at No comments:
Labels: , ,

Companion Diagnostics Market Will Make a Huge Growth by Emerging Tech

Companion Diagnostics Market

Companion diagnostics offers a set of tools that facilitates biological and clinical information to the pharmaceutical companies that they have to overcome. Companion diagnostics help physicians to improve the treatment decisions for the patients depending on their response to current treatments. Companion diagnostics approach to medication is transforming the healthcare industry by eliminating unfavorable reactions, improving treatment outcomes, and reducing the cost and time difficulties associated with conventional methods of medication.


On the basis of technology, the companion diagnostics market can be bifurcated as immunohistochemistry test (IHC), polymerase chain reaction tests (PCR), in situ hybridization tests (ISH), and others. Based on the indications, the global companion diagnostics market can be categorized as breast cancer, gastric cancer, colorectal cancer, melanoma, lung cancer, and others. Further on the bases of end users, the global companion diagnostics market can be categorized as reference laboratories, pharmaceutical companies and others.


Increasing scope for companion diagnostics and emerging technologies, such as next-generation sequencing (NGS), are some of the major opportunities for the global companion diagnostics market. Some of the major factors driving the growth of global companion diagnostics market are growing adoption of companion diagnostics by pharmaceutical companies and reference laboratories, regulatory bodies encouraging implementation of companion diagnostics, increasing demand and developmental of personalized medicine and rising demand for targeted cancer treatment.

North America had the largest companion diagnostics market because of the increasing incidence of cancer and increased healthcare awareness. Whereas, Asia-Pacific is the fastest growing market of companion diagnostics owing to the strengthening healthcare services and increasing medical tourism in developing countries such as India and China.

Some of the major competitors in companion diagnostics market are Biogenex Laboratories Inc, Agilent Technologies, Inc., Abbott Laboratories, Inc., Beckman Coulter, Inc., Danaher Corporation, Myriad Genetics, Inc., Qiagen N.V., bioMérieux SA, F. Hoffmann-La Roche AG, and General Electric Company.
Posted by at No comments:
Labels: , , ,

Tuesday, June 26, 2018

Life Science Instrumentation Market Overview with Qualitative Analysis, Competitive Landscape & Forecast 2023


Life Science Instrumentation Market
The global life science instrumentation market is growing due to the technological advancements, increase in funding for life science research, and increasing food safety concerns. Moreover, the increasing research and development activities in pharmaceuticals and biotechnology industries are supporting the growth of the global market. Among the various technologies, next-generation sequencing segment would witness the fastest growth during the forecast period. 

 Request to Get the Sample Report@ https://www.psmarketresearch.com/market-analysis/life-science-instrumentation-market/report-sample

 Increasing compliance for hyphenated technologies and increasing collaborations between analytical instrument manufacturers and academic and research institutes are other trends witnessed in the global life science instrumentation market. However, dearth of skilled professionals and high cost of analytical instruments would hinder the growth of the global market to some extent.

 Explore Full Report Description At@ https://www.psmarketresearch.com/market-analysis/life-science-instrumentation-market

 Geographically, North America accounted for the largest share in the global life science instrumentation market in 2015. Some of the major factors driving the North American market are; presence of a large number of pharmaceuticals and biotechnology companies, increasing number of research and development activities, and high compliance for advanced analytical instruments. The U.S. contributed largest revenue to the North American as well as global life science instrumentation market. The country is expected to remain the largest market for life science instrumentation globally during the forecast period.

Europe was the second largest market for life science instrumentation in 2015. The European life science instrumentation market is primarily driven by ongoing research and development activities in pharmaceutical and biotechnology industries and technological advancements in life science instrumentation. Germany accounted for the largest share in the European life science instrumentation market in 2015. The life science instrumentation market in Asia-Pacific would witness highest growth during the forecast period. The key factors leading to the highest growth in the region are growing pharmaceutical and biotechnology industries, large end user base and strategic expansion of major market players in the emerging economies of the region especially India and China. 

Make Enquiry Before Buying the Report@ https://www.psmarketresearch.com/send-enquiry?enquiry-url=life-science-instrumentation-market                                                      
The key players operating in the global life science instrumentation market are Danaher Corporation, Agilent Technologies, Inc., Shimadzu Corporation, Thermo Fisher Scientific Inc., PerkinElmer Inc., Becton, Dickinson and Company, Bruker Corporation, Bio-Rad Laboratories, Inc. and Waters Corporation.
Posted by at No comments:
Labels: , ,

Monday, June 25, 2018

Revenue Cycle Management Market in Healthcare Industry | Market Research Report Foresight by 2023


   

 The worldwide revenue cycle management market is witnessing considerable growth due to increasing regulatory requirements for the usage of revenue cycle management, increase in recovery audits due to changing healthcare regulations and increasing government support for revenue cycle management. Moreover, process improvements in healthcare organizations, increasing prevalence of chronic diseases and growing geriatric population are resulting in increased demand of revenue cycle management. Increasing number of patients and growth in demand for health insurance, increasing healthcare delivery cost, and decline in reimbursement rates are further supporting the market growth.

 Request to Get the Sample Report@ https://www.psmarketresearch.com/market-analysis/revenue-cycle-management-market/report-sample

 The increasing demand for cloud based revenue cycle solution and vendor consolidation to provide end-to-end solution are expected to create opportunities for the players in the market. In addition, immense unexplored market in developing economies are creating abundant opportunities for the revenue cycle management market to grow at a significant rate in the coming years. However, high cost of deployment, lack of data security, limited trained IT personnel, and infrastructural loop holes in developing countries are the key factors hampering the growth of the global market.

 Explore Full Report Description At@ https://www.psmarketresearch.com/market-analysis/revenue-cycle-management-market

 Geographically, North America has been the largest market for revenue cycle management, owing to presence of large number of market players and compliance encouraging the use of revenue cycle management solution in the region. The U.S. contributed largest revenue to the North American as well as global revenue cycle management market. Some of the major trends of the U.S. revenue cycle management market are revenue cycle management outsourcing, single payer systems, and declining reimbursement rates promoting value based payment models and predictive analytics. Increase in recovery audits due to changing healthcare regulations and increased investment in healthcare IT solution are driving the growth of the U.S. revenue cycle management market.

 Globally, the revenue cycle management market is expected to witness the fastest growth in Asia-Pacific during the forecast period. The highest growth in the region is attributed to increasing demand for healthcare insurance, growing geriatric population, increasing prevalence of chronic diseases and increasing demand for better healthcare in the region.

 Make Enquiry Before Buying the Report@ https://www.psmarketresearch.com/send-enquiry?enquiry-url=revenue-cycle-management-market

 The key players operating in the global market are Cerner Corporation, McKesson Corporation, Athenahealth Inc., Eclinicalworks LLC., Quest Diagnostics Incorporated, Allscripts Healthcare Solutions Inc., GE Healthcare, and Epic Systems Corporation.
Posted by at No comments:
Labels: , ,

Friday, June 22, 2018

Mental Health Software Market Global Outlook of Opportunities 2023

Mental Health Software Market

The global mental health software market is growing significantly, due to high potential of subscription model. During the forecast period, the providers segment is expected to hold the largest share, among all the end user segments of the global mental health software market, due to its extensive use for maintaining patient records and management revenue cycle. However, the residential segment is expected to grow with the highest rate during the forecasted period, due to increasing use of behavioral/ mental health solution by patients in their homes for better self-care.
Some of the factors driving the growth of the global market of mental health software are increasing government funding and support to improve behavioral healthcare services, behavioral health modifications, increasing healthcare expenditure, and increasing number of people pursuing behavioral health support. In addition, the increasing awareness among residential users and increasing adoption of electronic health record systems are also driving growth of the global market. However, the lack of data privacy, lack of skilled healthcare staff and physiatrists, difficulty in integration, and low adoption rate of the software are some of the factors, restraining the growth of the global mental health software market.
Geographically, North America is expected to dominate the global market in the coming years, due to increasing government support and increasing patient base seeking behavioral services. Asia is expected to be the fastest growing region, due to increasing healthcare expenditure and increasing government initiatives and support within the region. In addition, the market in Asia is growing, due to increasing awareness about mental health software in the emerging countries, such as India and China.
Some of the companies operating in the global mental health software market are Epic Systems Corporation, McKesson Corporation, Cerner Corporation, MindLinc, Allscripts,The Echo Group, Netsmart Technologies Inc., Qualifacts Systems Inc., Practice Fusion, General Electric Company, eClinicalWorks, Core Solutions Inc., Welligent Inc., and Valant Inc.


Posted by at No comments:
Labels: , ,

Home Healthcare Market - Current Trend, Emerging Technology and Future Opportunities

Home Healthcare Market

The global home healthcare market is growing significantly due to technological advancement and new healthcare services in the industry. Massive unexplored market in home healthcare industry of developing economies and cost effective alternatives to other modalities and facility based care are creating ample opportunities for the home healthcare market to grow at a considerable rate in the coming years. The advanced research and development facilities and new product developments by the companies are supporting to address the demand for cost effective healthcare in the home healthcare industry.


The home healthcare market can be categorized on the basis of services as rehabilitation services, unskilled home healthcare services, infusion therapy services, respiratory therapy services, and telehealth and telemedicine services. Diagnostic and monitoring devices lead the home healthcare market under type of devices category, due to increasing prevalence of chronic diseases such as diabetes and cardiovascular diseases. The therapeutic home healthcare devices segment is expected to grow with the fastest rate in the coming years, due to technological advancement in therapeutic devices.


Some of the factors driving the growth of home healthcare market are rise in geriatric population, high acceptance of home based services and medical devices, increasing sedentary lifestyle, increasing healthcare expenditure, and increasing prevalence of chronic diseases. However, fatal health disorders, misguide treatment therapy, and limited geographic presence of home healthcare service providers are some of the factors restraining the growth of the home healthcare market to some extent.

Geographically, North America will be leading the global home healthcare market in the coming years, due to rise in aging population, favourable reimbursement policies, and increasing sedentary lifestyle. Moreover, Asia-Pacific is the fastest growing region in the global home healthcare market. The major reasons for the fastest growth in the region are increasing healthcare expenditure and high standards of living of the consumers in the region. Moreover, the home healthcare market is growing due to increasing awareness of healthcare in the emerging countries, such as India and China of Asia-Pacific region.


Some of the companies operating in the home healthcare market are 3M Healthcare, Becton Dickinson and Company, Baxter International, Inc., Abbott Laboratories, Hoffmann-La Roche Ltd., Philips Healthcare, Apria Healthcare Group, Inc., Johnson & Johnson Services, Inc., Bayer AG, Eli Lilly and Company, C.R. Bard, Inc., B. Braun Melsungen AG, Carefusion Corporation, Coloplast A/S, Convatec Inc., Medtronic, Inc., and GE Healthcare.

Posted by at No comments:
Labels: , , ,

Bioinformatics Market | Overview | Applications | Products and Services | Sectors and Geographies

Bioinformatics Market

The introduction and adoption of cloud computing and nanopore technology are expected to offer numerous opportunities in the global bioinformatics market. The nanopore technology has been projected for getting used in the study of crop science, deoxyribonucleic acid (DNA), ribonucleic acid (RNA), proteins and small molecules with a range of applications in personalized medicine, and scientific research.


Bioinformatics is a discipline that deals with the retrieval, storage, processing, management and analysis of organic information through computational techniques. Bioinformatics plays an important role in drug innovation and improvement. The involvement of bioinformatics in storing, retrieving, analyzing and forming biological information helps in efficiently managing enormous database associated with drug innovation and development.


Bioinformatics technologies are used in various pharmaceutical and biotechnology sectors. They are mainly used in the medical sector, which is driven by the increasing use of bioinformatics for the drug development and discovery process. Falling prices of DNA sequencing and increasing government initiatives to boost bioinformatics based life sciences research activities are the two major growth drivers of the global bioinformatics market. Some of the other drivers contributing to growth the of global bioinformatics market includes, increasing demand for bioinformatics as a consulting solution by pharmaceutical manufacturers and medical devices, in an effort to accelerate and improve manufacturing processes, with the increasing need for bioinformatics in data incorporation and warehousing.


Moreover, the use of bioinformatics helps in optimizing the research and development process by post clinical trials and thoroughly managing the large amount of data, thereby accelerating and simplifying the process of drug target acknowledgement.

North America dominated the global bioinformatics market in 2013, by holding approximately 42% of the market share. The availability of encouraging government support in terms of funding and large number of research initiatives carried out in the region are some of the factors responsible for worldwide dominance of the region. The Asia-Pacific bioinformatics market is projected to be the fastest growing regional market in the forecast period. High availability of trained labors in countries such as, China and India with low labor costs has inspired manufacturers to stick upon contract research outsourcing strategies for limiting costs, which has enormously contributed to the growth of Asia-Pacific bioinformatics market.


Some of the key competitors within the global bioinformatics market include Tripos, LP, Affymetrix, Inc, Agilent Technologies, Illumina, Inc., Helicos Biosciences Corporation, IBM Life Sciences, Thermo Fisher Scientific Inc, Rosetta Inpharmatics LLC, Celera and others.

Posted by at No comments:
Labels: , , , ,

Thursday, June 21, 2018

Topical Drug Delivery Market Business Overview, Challenges, Opportunities, Trends and Market Analysis by 2023


Topical Drug Delivery Market

Drugs that are applied to a local area on the body are known as topical drugs. Many creams and balms that are used for skin treatment are frequently called topical drug. 

Eye drops for ophthalmic use and various drugs utilized for inward breath in respiratory conditions such as asthma are also frequently known as topical medications. Topical medications have a local effect that means the effect of the drug will be only in the area where the drug has been applied; however, some topical medications can also have a systemic effect.



On the basis of route of administration, global topical drug delivery market is segmented into skin, ophthalmic, nasal, rectal and vaginal drug delivery routes. Skin drug delivery holds the largest share of the global market, which is attributable to the high incidence of skin diseases, rise in the demand for self-administered drugs, and the increasing number of product approvals for skin-related drug delivery systems.



There are various factors that drive the growth of the topical drug delivery market including the increasing prevalence of dermal diseases, development of high technology in topical drug delivery systems, high number of cases of burn injuries, and increasing prevalence of diabetes, globally. 

According to the information published by Pharmaceuticals Research and Manufacturers of America (PhRMA), the member organizations of PhRMA spent approximately $58.8 billion on R&D, accounting for the larger part of all the biopharmaceutical R&D spending in the U.S., in 2015. 


Some of the other key players operating in the global topical drug delivery market include Crescita Therapeutics Inc., SOLVAY S.A., Bayer AG, Cipla Limited, Galderma S.A, GlaxoSmithKline PLC, Janssen Global Services, LLC. (Johnson and Johnson), Novartis International AG, Sienna Biopharmaceuticals, Inc., Allergan PLC.


Posted by at No comments:
Labels: , ,
Subscribe to: Posts (Atom)